Syrah Resources Valuation

Is 3S7 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 3S7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 3S7's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 3S7's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 3S7?

Key metric: As 3S7 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 3S7. This is calculated by dividing 3S7's market cap by their current revenue.
What is 3S7's PS Ratio?
PS Ratio3.9x
SalesUS$38.37m
Market CapUS$148.01m

Price to Sales Ratio vs Peers

How does 3S7's PS Ratio compare to its peers?

The above table shows the PS ratio for 3S7 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.6x
2HRA H&R GmbH KGaA
0.1x3.0%€128.4m
NTG Nabaltec
0.6x5.1%€122.3m
BNN BRAIN Biotech
1.3x8.5%€70.8m
UZU Uzin Utz
0.5x4.3%€250.2m
3S7 Syrah Resources
3.9x43.1%€227.7m

Price-To-Sales vs Peers: 3S7 is expensive based on its Price-To-Sales Ratio (3.9x) compared to the peer average (0.6x).


Price to Sales Ratio vs Industry

How does 3S7's PS Ratio compare vs other companies in the European Metals and Mining Industry?

35 CompaniesPrice / SalesEstimated GrowthMarket Cap
3S7 3.9xIndustry Avg. 0.7xNo. of Companies35PS00.81.62.43.24+
35 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 3S7 is expensive based on its Price-To-Sales Ratio (3.9x) compared to the European Metals and Mining industry average (0.7x).


Price to Sales Ratio vs Fair Ratio

What is 3S7's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

3S7 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio3.9x
Fair PS Ratio0.008x

Price-To-Sales vs Fair Ratio: 3S7 is expensive based on its Price-To-Sales Ratio (3.9x) compared to the estimated Fair Price-To-Sales Ratio (0x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 3S7 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.13
€0.34
+164.9%
36.8%€0.49€0.19n/a5
Nov ’25€0.17
€0.34
+103.5%
36.3%€0.48€0.19n/a5
Oct ’25€0.15
€0.35
+129.1%
38.5%€0.49€0.18n/a5
Sep ’25€0.15
€0.40
+173.3%
32.0%€0.48€0.15n/a5
Aug ’25€0.15
€0.40
+158.1%
32.0%€0.48€0.15n/a5
Jul ’25€0.21
€0.49
+134.9%
29.5%€0.68€0.25n/a5
Jun ’25€0.27
€0.49
+84.9%
24.8%€0.67€0.31n/a5
May ’25€0.31
€0.53
+71.1%
26.0%€0.67€0.30n/a4
Apr ’25€0.31
€0.52
+68.1%
28.8%€0.66€0.27n/a4
Mar ’25€0.40
€0.54
+35.7%
36.0%€0.78€0.24n/a4
Feb ’25€0.23
€0.57
+149.8%
26.3%€0.79€0.36n/a4
Jan ’25€0.39
€0.59
+51.8%
25.4%€0.78€0.36n/a4
Dec ’24€0.35
€0.59
+70.1%
25.4%€0.78€0.36n/a4
Nov ’24€0.40
€0.60
+48.5%
25.4%€0.78€0.36€0.174
Oct ’24€0.30
€0.65
+120.8%
26.6%€0.79€0.36€0.154
Sep ’24€0.33
€0.70
+111.0%
18.4%€0.79€0.51€0.153
Aug ’24€0.46
€0.70
+52.9%
18.4%€0.79€0.51€0.153
Jul ’24€0.54
€0.87
+62.3%
29.2%€1.22€0.61€0.213
Jun ’24€0.50
€0.94
+87.9%
20.9%€1.22€0.76€0.273
May ’24€0.69
€1.12
+62.4%
24.6%€1.41€0.75€0.313
Apr ’24€1.17
€1.32
+12.9%
11.6%€1.45€1.11€0.313
Mar ’24€1.17
€1.43
+22.0%
5.6%€1.51€1.35€0.402
Feb ’24€1.39
€1.44
+4.0%
5.6%€1.53€1.36€0.232
Jan ’24€1.33
€1.46
+9.5%
3.3%€1.50€1.41€0.392
Dec ’23€1.60
€1.35
-15.7%
11.9%€1.51€1.19€0.352
Nov ’23€1.58
€1.35
-14.7%
11.9%€1.51€1.19€0.402

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies